Clinical Trial Update: Adderall XR and Processing Speed in Multiple Sclerosis (MS) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Adderall XR evaluating processing speed in individuals with Multiple Sclerosis across Phase 2 and Phase 3; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Adderall XR (mixed amphetamine salts)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Impaired Processing Speed, Cognitive Impairment | Phase 2, Phase 3 | Status: COMPLETED